Yaz, Yasmin and Ocella
Yaz and Yasmin are oral contraceptive pills manufactured by Bayer Pharmaceuticals. Yaz and Yasmin are known generically as a combination of drospirenone and ethinyl estradiol. Yaz received U.S. Food and Drug Administration (FDA) approval in 2006, while Yasmin received FDA approval in 2001.
In marketing campaigns, the pharmaceutical giant claimed Yaz was an oral contraceptive that could also be used to treat premenstrual dysphoric disorder (PMDD). Yasmin was marketed by Bayer as an oral contraceptive.
There are a large number of reports alleging a strong link between the use of Yaz or Yasmin and the occurrence of a heart attack or a stroke in women. Furthermore, the incidence of blood clot formation while taking Yaz or Yasmin is also a common and severe side effect of using these oral contraceptives. There have also been cases of Yaz and Yasmin related deaths.
Side effects of Yaz and Yasmin include, but are not limited to, the following:
- Heart attack
- Brain hemorrhage
- Pulmonary embolism
- Deep vein thrombosis (DVT)
- Blood clot formation
If you or someone you love has suffered from the use of Yaz or Yasmin, you and your loved one may be entitled to receive compensation for you suffering and losses. For a free legal consultation about filing a Yaz lawsuit or a Yasmin lawsuit, contact an experienced Yaz and Yasmin lawyer at Carey Danis & Lowe today.
Common Yaz & Yasmin Side Effects Can Include:
- Sudden Death
- Pulmonary Embolisms
- Blood Clots
- Heart Attack
- Deep Vein Thrombosis (DVT)
- Venous Thromboembolism (VTE)
- Other Related Side Effects & Injuries
Yaz, Yasmin, Ocella (Drospirenone/Ethinyl Estradiol)
FDA Approval: May 11, 2001 (Yasmin), March 16, 2006 (Yaz) as oral contraceptive, PMDD & mild acne treatment
Generic Availability: N/A